Skip to main content

Table 1 Profile of patients at their first visit during reporting period Q1 2018 – Q3 2019, Ulaanbaatar

From: Implementing a multisector public-private partnership to improve urban hypertension management in low-and middle- income countries

 

Diagnosed

Treated

Controlled BP (at the last visit)

Among all patients, with data

Total N = 11,189

%

Total N = 10,075

%

Total N = 1986

%

Treated Crude OR (95% CI)

BP Controlled Crude OR (95% CI)

Age (years)

 18–29

150

1·3

83

0 8

8

0·4

REF

REF

 30–44

1050

9·4

800

7·9

107

5·4

2·6 (1·8, 3·7) ¥¥¥

2·0 (0·9, 4·9)

 45–59

3811

34·1

3385

33·6

579

29·2

6·4 (4·5, 9·1) ¥¥¥

3·2 (1·6, 7·5) ¥¥¥

 60–69

3496

31·2

3279

32·5

639

32·3

12·2 (8·4, 17·5) ¥¥¥

4·0 (1·9, 9·4) ¥¥¥

 70–79

1918

17·1

1800

17·9

463

23·4

12·3 (8·3, 18·1) ¥¥¥

5·6 (2·8, 13·4) ¥¥¥

  ≥ 80

729

6·5

693

6·9

190

9·6

15·5 (9·5, 25·5) ¥¥¥

6·2 (3·0, 15·0) ¥¥¥

 Missing age information

35

0·3

35*

0·3

0**

0·0

NA

NA

Sex

      

REF: MEN

REF: MEN

 Women

7029

62·8

6371

63·2

1344

67·8

1·2 (1·0, 1·4) ¥¥

1·3 (1·2, 1·5) ¥¥¥

 Missing sex information

13

0·1

12

0·1

3

0·2

NA

NA

BP Categories (mmHg)

  < 120 and < 80 mmHg

362

3·2

335

3·3

90

4·5

REF

REF

 120–129 or 80–84 mmHg

704

6·3

672

6·7

170

8·6

1·7 (1·0, 3·0) ¥

1·0 (0·7, 1·3)

 130–139 or 85–89 mmHg

2252

20·1

1871

18·6

331

16·7

0·4 (0·3, 0·6) ¥¥¥

0·5 (0·4, 0·7) ¥¥¥

 140–159 or 90–99 mmHg

3632

32·5

3184

31·6

433

21·9

0·6 (0·4, 0·9) ¥¥

0·4 (0·3, 0·5) ¥¥¥

 160–179 or 100–109 mmHg

2185

19·5

2014

20·0

328

16·6

0·9 (0·6, 1·5)

0·5 (0·4, 0·7) ¥¥¥

  ≥ 180 or ≥ 110 mmHg

726

6·5

680

6·7

109

5·5

1·2 (0·7, 2·0)

0·5 (0·4, 0·7) ¥¥¥

 Missing BP information

1328

11·9

1319***

13·1

525***

26·5

NA

NA

CV Riska

 Low

3636

32·5

3511

34·8

690

34·8

REF

REF

 Moderate/Intermediate

2874

25·7

2816

28·0

406

20·5

1·7 (1·3, 2·4) ¥¥¥

0·7 (0·6, 0·8) ¥¥¥

 High

565

5·0

547

5·4

99

5·0

1·1 (0·7, 1·9)

0·9 (0·7, 1·1)

 Missing

4144

37·0

3201***

31·8

791**

39·9

NA

NA

  1. Chi-square test or statistical significance for missingness of patient characteristic data *p < 0·05, **p < 0·01, ***p < 0·001
  2. BP blood pressure, CI confidence intervals, CV cardiovascular, NA not applicable, OR odds ratio, REF reference
  3. aCV risk was defined according to city-specific guidelines (see S3 Table)
  4. Crude odds ratios and 95% CIs estimated only among patients with non-missing data and rounded to one decimal place; ¥p < 0·05, ¥¥p < 0·01, ¥¥¥p < 0·001